Design of microencapsulated chitosan microspheres for colonic drug delivery

Journal of Controlled Release

Volumn 52, Issue 1-2, 1998, Pages 109-118

  Lorenzo Lamosa, M L ^a   Remunan Lopez C ^a   Vila Jato, J L ^a   Alonso, M J ^a  

^a Univ Santiago C   (Spain)

Author keywords

Chitosan; Colon drug delivery; Eudragit ; Eudragit chitosan interactions; Microencapsulation; Solvent evaporation; Spray drying

Indexed keywords

CHITOSAN; DICLOFENAC; EUDRAGIT; MICROSPHERE;

ADULT; ARTICLE; BIODEGRADATION; COLON; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; INFRARED SPECTROSCOPY; MALE; MICROENCAPSULATION; NORMAL HUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SALIVA ANALYSIS;

CHITIN; CHITOSAN; COLON; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; MICROSPHERES; POLYMETHACRYLIC ACIDS;

EID: 0032473392     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00203-4     Document Type: Article

References (25)

1. Tozer T.N., Friend D.R., Mcleod A.D. Kinetic perspectives on colonic delivery. STP Pharma Sci. 5:1995;5-12.
2. Yeh P.-Y., Berenson M.M., Samowitz W.S., Kopecková P., Kopecek J. Site-specific drug delivery and penetration enhancement in the gastrointestinal tract. J. Control. Release. 36:1995;109-124.
3. Rubinstein A. Approaches and opportunities in colon-specific drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 12(12&3):1995;101-149.
4. Sack D.M., Peppercorn M.A. Drug therapy of inflamatory bowel disease. Pharmacotherapy. 3:1983;158-176y.
5. Friend D.R. Colon-specific drug delivery. Adv. Drug Deliv. Rev. 7:1991;149-199.
6. Brondsted H., Kopecek J. Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation. Pharm. Res. 9:1992;1540-1545.
7. Kopecková P., Rathi R., Takada S., Rihová B., Berenson M.M., Kopecek J. Bioadhesive N-(2-hydroxypropyl)methacrylamide copolymers for colon-specific drug delivery. J. Control. Release. 28:1994;211-222.
8. Rubinstein A., Nakar D., Sintov A. Chondroitin sulfate: a potential biodegradable carrier for colon-specific drug delivery. Int. J. Pharm. 84:1992;141-150.
9. Ashford M., Fell J., Attwood D., Sharme H., Woodhead P. Studies on pectin formulations for colonic drug delivery. J. Control. Release. 30:1994;225-232.
10. J. Knapczyk, L. Krówczynski, J. Krzek, M. Brzeski, E. Nurnberg, D. Schenk, H. Struszcyk, Requirements of chitosan for pharmaceutical and biomedical applications, in: G. Skåk-Bræk, T. Anthonsen, P. Sandford (Eds.), Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, Elsevier Applied Sciences, London, 1989, pp. 657-663.
11. S. Hirano, H. Seino, I. Akiyama, I. Nonaka, Chitosan: a biocompatible material for oral and intravenous administrations, in: C.G. Gebelein, R.L. Dunn (Eds.), Progress in Biomedical Polymers, Plenum Press, New York, 1990, pp. 283-289.
12. Lehr C.M., Bouwstra J.A., Schacht E.H., Jungiger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78:1992;43-48.
13. M.L. Weiner, An overview of the regulatory status and of the safety of chitin and chitosan as food and pharmaceutical ingredients, in: C.J. Brine, P.A. Sandford, J.P. Zikakis (Eds.), Advances in Chitin and Chitosan, Elsevier Applied Sciences, London, 1993, pp. 663-672.
14. Berthold A., Cremer K., Kreuter J. Influence of crosslinking on the acid stability and physicochemical properties of chitosan microspheres. STP Pharma Sci. 6:1996;358-364.
15. Thanoo B.C., Sunny M.C., Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol. 44:1992;283-286.
16. Akbuga J., Durmaz G. Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Int. J. Pharm. 11:1994;217-222.
17. Gleiter C.H., Antonin K.H., Bieck P., Godbillon J., Schönleber W., Malchow H. Colonoscopy in the investigation of drug absorption in healthy volunteers. Gastrointest. Endosc. 31:1985;71-73.
18. Levy M., Benita S. Drug release from submicronized O/W emulsion: a new in vitro kinetic evaluation model. Int. J. Pharm. 66:1990;29.
19. Genta I., Pavaneto F., Conti B., Giunchedi P., Conte U. Improvement of dexamethasone dissolution rate from spray-dried chitosan microspheres. STP Pharm. Sci. 5(3):1995;202-207.
20. Dangprasirt P., Ritthidej G.C. Development of diclofenac sodium controlled release solid dispersions by spray drying using optimization strategy I. Powder formulation. Drug Dev. Ind. Pharm. 21(20):1995;2323-2337.
21. Remuñán-López C., Bodmeier R. Mechanical and water vapor transmission properties of polysaccharide films. Drug Dev. Ind. Pharm. 22:1996;1201-1209.
22. Aftabrouchad C., Doelker E. Preparation methods for biodegradable microparticles loaded with water-soluble drugs. STP Pharma Sci. 2(5):1992;365-380.
23. Adusumilli P.S., Bolton S.M. Evaluation of chitosan citrate complexes as matrices for controlled release formulations using a 32 full factorial design. Drug Dev. Ind. Pharm. 17:1991;1931-1945.
24. Röhm Pharma, Information Sheets 'Eudragit Polymethacrylate for Pharmaceutical Applications', 1995.
25. Fukuda H. Polyelectrolyte complexes of sodium carboxymethylcellulose with chitosan. Makromol. Chem. 180:1979;1631-1633.